3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Teva Branded Pharmaceutical Products R&D, Inc.
National Institutes of Health Clinical Center (CC)